Eam Global Investors LLC Chemo Centryx, Inc. Transaction History

Eam Global Investors LLC

$435 Million
Q3 2024

Shares

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2020 Nov 13, 2020	SELL	$46.35 - $61.69 $1.52 Million - $2.02 Million	-32,809 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$38.58 - $65.07 $1.66 Million - $2.79 Million	-42,944 Reduced 56.69%	32,809 $1.89 Million
Q1 2020 May 13, 2020	SELL	$32.73 - $50.78 $257,159 - $398,978	-7,857 Reduced 9.4%	75,753 $3.04 Million
Q4 2019 Feb 10, 2020	BUY	$6.81 - $39.55 $569,384 - $3.31 Million	83,610 New	83,610 $3.31 Million

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Global Investors LLC with notifications on news.